However, studies on AD patients revealed an inability of TTR to bind its natural ligand [89] and a decreased ratio of folded/monomeric TTR in plasma [86], which suggests a deficit in functional TTR molecules. The gene discussed is TTR; the disease is Alzheimer disease.